A new molecule could protect the brain from cognitive impairments after a mild traumatic brain injury, according to scientists. Mild traumatic brain injury, or mTBI, is especially common in children, athletes, and the elderly. Further studies could establish the potential for a single dose of TXM-peptides to prevent damage if administered even one hour after brain trauma.